Adma Biologics Inc (ADMA)

SG&A Expenses

$100.04M

TTM · Period ending: · USD

ADMA logo

ADMA SG&A Expenses

Latest reported$100.04M
ADMA TTM SG&A Expenses ($40.96M → $100.04M)
High-resolution chart · PNG

ADMA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adma Biologics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
100,039,000
95,516,000
92,853,000
92,658,000
88,170,000
82,564,000
74,124,000
66,341,999
62,507,999
60,147,999
59,020,999
57,380,888
55,548,027
53,270,449
52,458,024
50,261,145
48,094,803
46,562,549
42,896,889
40,499,239
38,888,186
37,152,648
35,050,817
32,782,525
30,863,954
28,247,371
25,910,757
26,013,965
24,172,586
23,093,346
22,502,922
20,551,984
19,391,654
18,820,497
18,092,835
16,192,092
13,775,743
11,064,256
8,494,742
7,095,518
7,394,569
7,107,842
6,745,969
5,973,593
4,930,647
5,035,277
4,823,869
4,710,510
4,520,591
4,068,817
4,365,334
4,062,945
4,252,174
3,898,806
3,142,289
2,449,893
1,419,213
697,203
26,464
26,464
26,464
21,580
21,730
21,380
3,836,530
3,826,500
14,771,500
21,895,000
42,992,000
59,084,000
59,357,000
52,234,250
57,053,250
40,963,250
29,743,250
29,751,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.